TrialLeukemia & lymphoma2012

Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplant.

Qaiser Bashir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.